FATE THERAPEUTICS INC Other
Cover page items of the 10-K and 10-Q that have no other home: a security other than the listed stock or a bond, a check box that differs from the latest cover, or a figure not in the Balance Sheet › Equity tabs. Newest first, as filed.
- 2026-02-26: Form 10-K; Item Stock registered under Section 12(b); As filed Common Stock, $0.001 par value · FATE · Nasdaq Global Market.
- 2025-03-05: Form 10-K; Item Stock registered under Section 12(b); As filed Common Stock, $0.001 par value · FATE · NASDAQ Global Market.
- 2024-02-26: Form 10-K; Item Stock registered under Section 12(b); As filed Common Stock, $0.001 par value · FATE · NASDAQ Global Market.
- 2023-11-08: Form 10-Q; Item Smaller reporting company; As filed No.
| Filed | Form | Item | As filed |
|---|
| 2026-02-26 | 10-K | Stock registered under Section 12(b) | Common Stock, $0.001 par value · FATE · Nasdaq Global Market |
|---|
| 2025-03-05 | 10-K | Stock registered under Section 12(b) | Common Stock, $0.001 par value · FATE · NASDAQ Global Market |
|---|
| 2024-02-26 | 10-K | Stock registered under Section 12(b) | Common Stock, $0.001 par value · FATE · NASDAQ Global Market |
|---|
| 2023-11-08 | 10-Q | Smaller reporting company | No |
|---|
| 2023-08-08 | 10-Q | Smaller reporting company | No |
|---|
| 2023-05-03 | 10-Q | Smaller reporting company | No |
|---|
| 2023-02-28 | 10-K | Stock registered under Section 12(b) | Common Stock, $0.001 par value · FATE · NASDAQ Global Market |
|---|
| 2023-02-28 | 10-K | Smaller reporting company | No |
|---|
| 2023-02-28 | 10-K | Well-known seasoned issuer | Yes |
|---|
| 2022-11-03 | 10-Q | Smaller reporting company | No |
|---|
| 2022-08-03 | 10-Q | Smaller reporting company | No |
|---|
| 2022-05-04 | 10-Q | Smaller reporting company | No |
|---|
| 2022-02-28 | 10-K | Stock registered under Section 12(b) | Common Stock, $0.001 par value · FATE · NASDAQ Global Market |
|---|
| 2022-02-28 | 10-K | Smaller reporting company | No |
|---|
| 2022-02-28 | 10-K | Well-known seasoned issuer | Yes |
|---|
| 2021-11-04 | 10-Q | Smaller reporting company | No |
|---|
| 2021-08-04 | 10-Q | Smaller reporting company | No |
|---|
| 2021-05-05 | 10-Q | Smaller reporting company | No |
|---|
| 2021-02-24 | 10-K | Stock registered under Section 12(b) | Common Stock, $0.001 par value · FATE · NASDAQ Global Market |
|---|
| 2021-02-24 | 10-K | Smaller reporting company | No |
|---|
| 2021-02-24 | 10-K | Well-known seasoned issuer | Yes |
|---|
| 2020-11-05 | 10-Q | Smaller reporting company | No |
|---|
| 2020-08-05 | 10-Q | Smaller reporting company | No |
|---|
| 2020-05-11 | 10-Q | Smaller reporting company | No |
|---|
| 2020-03-02 | 10-K | Stock registered under Section 12(b) | Common Stock, $0.001 par value · FATE · NASDAQ |
|---|
| 2020-03-02 | 10-K | Smaller reporting company | No |
|---|
| 2020-03-02 | 10-K | Well-known seasoned issuer | Yes |
|---|
| 2019-11-05 | 10-Q | Stock registered under Section 12(b) | Common Stock · FATE · NASDAQ |
|---|
| 2019-03-05 | 10-K | Well-known seasoned issuer | Yes |
|---|
| 2018-11-01 | 10-Q | Smaller reporting company | No |
|---|
| 2018-11-01 | 10-Q | Emerging growth company | Yes |
|---|
| 2013-11-13 | 10-Q | Current in its reporting | No |
|---|
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|
| Liminatus Pharma, Inc. (LIMN) | United States | $0.282B | |
|---|
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
|---|
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
|---|
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
|---|
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
|---|
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
|---|
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
|---|
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
|---|
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
|---|
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
|---|